Microbix Biosystems (TSX:MBX) Margin of Safety % (DCF FCF Based) : N/A (As of Dec. 15, 2024)

View and export this data going back to 1992. Start your Free Trial

What is Microbix Biosystems Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Microbix Biosystems's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.

Competitive Comparison of Microbix Biosystems's Margin of Safety % (DCF FCF Based)

For the Biotechnology subindustry, Microbix Biosystems's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Microbix Biosystems's Margin of Safety % (DCF FCF Based) Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Microbix Biosystems's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Microbix Biosystems's Margin of Safety % (DCF FCF Based) falls into.

Microbix Biosystems Margin of Safety % (DCF FCF Based) Related Terms

Thank you for viewing the detailed overview of Microbix Biosystems's Margin of Safety % (DCF FCF Based) provided by GuruFocus.com. Please click on the following links to see related term pages.

Microbix Biosystems Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Microbix Biosystems Inc (TSX:MBX) » Definitions » Margin of Safety % (DCF FCF Based)

Comparable Companies

Traded in Other Exchanges

MBXBF:USA

Address

265 Watline Avenue, Mississauga, ON, CAN, L4Z 1P3

Website

https://www.microbix.com

Microbix Biosystems Inc develops biological products and technologies. The company manufactures and develops cell culture-based biological products and technologies. It has developed and acquired two technologies; Kinlytic and LumiSort. The company's operating segment includes Antigen, QAPs DxTM and Other Includes Kinlytic. It generates maximum revenue from the Antigen QAPs segment. Geographically, it derives a majority of revenue from North America.

Executives

Cameron Lionel Groome	Director, Senior Officer
Bo Hollas	Director
Steven Trevor Hagerman	Senior Officer
Jennifer Anne Stewart	Director
James Stuart Currie	Senior Officer
Damian Klimaszewski	Senior Officer
Kenneth Hughes	Senior Officer
Anthony J. Giovinazzo	Director
Martin Marino	Director
Mark Adrian Luscher	Senior Officer
Peter Martin Blecher	Director